Status:
COMPLETED
Evaluation of Conjunctival Autografting With MMC Application Versus Ologen Implantation of Recurrent Pterygium
Lead Sponsor:
Menoufia University
Conditions:
Recurrent Pterygium of Eye
Eligibility:
All Genders
Phase:
NA
Brief Summary
Ologen implantation with conjunctival autografting shows promising results in surgical management of recurrent pterygium comparable to MMC application with conjunctival autografting with mild non visi...
Detailed Description
Patients were randomly enrolled into two groups. Group A included 32 eyes of 32 patients who underwent conjunctival autografting augmented with topical application of Mitomycin C (0.2 mg/mL). Group B ...
Eligibility Criteria
Inclusion
- recurrent nasal pterygium after one surgical session for removal of the primary one
Exclusion
- primary nasal pterygium,
- recurrent pterygium with more than one session for surgical removal
Key Trial Info
Start Date :
January 15 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT04419038
Start Date
January 15 2016
End Date
December 30 2019
Last Update
June 5 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.